CYP2C9 c.1003C>T

CYP2C9 c.1003C>T

The CYP2C9 c.1003C>T Novallele Genotyping Assay identifies a single mutation associated with the CYP2C9*11 allele. The CYP2C9*11 allele may cause reduced warfarin metabolism. Inhibited warfarin metabolism is characterized by bleeding tendency and thromboembolic diseases, such as pulmonary embolism and stroke.

£177.00

Get in touch

Get in touch with the team

  • :

Product Description

The CYP2C9 c.1003C>T Novallele Genotyping Assay is used to amplify and identify specific genetic polymorphisms or mutations. This assay provides scientists with a simple way to quickly genotype this locus from isolated human genomic DNA. The assay contains functionally-verified oligonucleotide primers necessary for PCR and subsequent allele identification by DNA melting. For Research Use Only. Not for use in diagnostic procedures.